China has launched a year-long anti-corruption crackdown in the Medical Sector, targeting collaborations between hospital administrators, doctors, and medical representatives. The campaign has disrupted the operations of multinational pharmaceutical companies, with hospitals barring medical representatives and halting sales operations. Over 155 officials at hospitals across China are being investigated for alleged violations, and the crackdown may delve into misconduct spanning the past two decades. The focus is on corruption cases in the pharmaceutical sector to create a deterrent effect. The crackdown has caused pharmaceutical stocks to plummet, and industry insiders believe it is aimed at addressing financial difficulties.

The post China’s medical Sector Faces Unprecedented anti-corruption crackdown appeared first on Balanced News Summary.